法舒地尔对不稳定型心绞痛患者血浆C-反应蛋白\内皮素\一氧化氮的影响(2)
http://www.100md.com
2010年5月1日
 |
| 第1页 |
参见附件(2600KB，3页)。
参考文献
[1]Hashimoto H,Kitagawa K,Hougaku H,et al.C-reactive protein is an independent predictor of the rate of increase in early carotid athe rosckerosis[J]. Circulation,2001,104(1):63.
[2]Huggins GS, Pasternak PC, Alpert NM, et al. Effects of short term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse [ J].Circulation, 1998, 98: 1291-1296.
[3] Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005, 352 (16):1685-1695.
[4] Mulvill NT, Foley JB. Inflammation in acute coronary syndromes[ J]. Heart, 2002, 87(3): 201-203.
[5] 李小鹰.心血管疾病分子生物学[ M].北京:人民军医出版社, 2000, 248.
[6] Kandabashi T, Shimokawa H, Miyata K, et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coron-ary artery spasm in a porcinemodel with interleukin-1beta. Circulation.2000; 101:1319–1323.
[7] Potteaux S, Esposito B, Oostrom O,et al.Leukocyte derived interleukin 10 is required for protection against atherosclerosis in lowdensity lipop rotein recep tor knockout mice[J]. Arterioscle Thromb Vasc Biol, 2004,24(8):1474-1478.
[8] Soejima H, Irie A, Miyamoto S,et al.Preference toward a Thelpertype 1 response in patientswith coronary spastic angina[J].Circulation, 2003,107(17):2196-2200.
[9] Masumoto A, Mohri M, Shimokawa H, et al. Suppression of coronary arteryspasm by the Rho-kinase inhibitor fasudil in patients with vasospasticangina. Circulation. 2002;105:1545-1547.
您现在查看是摘要介绍页，详见PDF附件(2600KB，3页)。